3529 related articles for article (PubMed ID: 6443174)
1. Production, purification and characterization of the plasminogen activator in teratocarcinoma stem cells induced with sodium butyrate.
Ichikawa N; Miyashita T; Nishimune Y; Matsushiro A
Biken J; 1984 Dec; 27(4):143-51. PubMed ID: 6443174
[TBL] [Abstract][Full Text] [Related]
2. Plasminogen activator and inhibitor activity in human glioma cells and modulation by sodium butyrate.
Gross JL; Behrens DL; Mullins DE; Kornblith PL; Dexter DL
Cancer Res; 1988 Jan; 48(2):291-6. PubMed ID: 3121170
[TBL] [Abstract][Full Text] [Related]
3. Teratocarcinoma F9 cells induced to differentiate with sodium butyrate produce both tissue-type and urokinase-type plasminogen activators.
Takeda M; Kosaka M; Nishina Y; Sawada K; Matsumoto K; Nishimune Y
J Cell Biochem; 1992 Jul; 49(3):284-9. PubMed ID: 1644865
[TBL] [Abstract][Full Text] [Related]
4. Differentiation of early mouse embryonic and teratocarcinoma cells in vitro: plasminogen activator production.
Sherman MI; Strickland S; Reich E
Cancer Res; 1976 Nov; 36(11 Pt. 2):4208-16. PubMed ID: 975058
[TBL] [Abstract][Full Text] [Related]
5. In vitro differentiation of teratomas and the distribution of creatine phosphokinase and plasminogen activator in teratocarcinoma-derived cells.
Topp W; Hall JD; Marsden M; Teresky AK; Rifkin D; Levine AJ; Pollack R
Cancer Res; 1976 Nov; 36(11 Pt. 2):4217-23. PubMed ID: 184930
[TBL] [Abstract][Full Text] [Related]
6. Plasminogen-activator in human early milk: its partial purification and characterization.
Okamoto U; Horie N; Nagamatsu Y; Yamamoto JI
Thromb Haemost; 1981 Apr; 45(2):121-6. PubMed ID: 7196095
[TBL] [Abstract][Full Text] [Related]
7. Characterization of plasminogen activator produced by an established cell line from human ovary.
Matsuo C; Fukao H; Matsuo O
J Cell Physiol; 1988 Feb; 134(2):253-60. PubMed ID: 3126195
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies to human 54,000 molecular weight plasminogen activator inhibitor from fibrosarcoma cells--inhibitor neutralization and one-step affinity purification.
Nielsen LS; Andreasen PA; Grøndahl-Hansen J; Huang JY; Kristensen P; Danø K
Thromb Haemost; 1986 Apr; 55(2):206-12. PubMed ID: 3520936
[TBL] [Abstract][Full Text] [Related]
9. Purification and characterization of the plasminogen activator secreted by a rat brain tumor cell line in culture.
Bykowska K; Rijken DC; Collen D
Thromb Haemost; 1981 Oct; 46(3):642-4. PubMed ID: 7198301
[TBL] [Abstract][Full Text] [Related]
10. Butyrate stimulates tissue-type plasminogen-activator synthesis in cultured human endothelial cells.
Kooistra T; van den Berg J; Töns A; Platenburg G; Rijken DC; van den Berg E
Biochem J; 1987 Nov; 247(3):605-12. PubMed ID: 2827633
[TBL] [Abstract][Full Text] [Related]
11. Partial purification and characterization of native plasminogen activators from bovine milk.
Deharveng G; Nielsen SS
J Dairy Sci; 1991 Jul; 74(7):2060-72. PubMed ID: 1894805
[TBL] [Abstract][Full Text] [Related]
12. A comparison of the effects of various stimulatory agents on t-PA secretion by normal and malignant cell lines.
Clarke J; Griffiths B; Melling J; Ling R; Atkinson T; Electricwala A
Cell Biochem Funct; 1989 Oct; 7(4):283-91. PubMed ID: 2481573
[TBL] [Abstract][Full Text] [Related]
13. Production of plasminogen activator in a melanoma cell line.
Matsuo O; Sakai T; Matsuo C; Nishida Y; Akazawa K; Mihara H
Acta Physiol Lat Am; 1983; 33(4):305-13. PubMed ID: 6377823
[TBL] [Abstract][Full Text] [Related]
14. Plasminogen activator production from murine mastocytoma cells. Dissociation of plasminogen activator and histamine production by sodium butyrate.
Katayama I; Hashimoto K; Nishioka K
Int Arch Allergy Appl Immunol; 1986; 81(1):42-5. PubMed ID: 2427454
[TBL] [Abstract][Full Text] [Related]
15. Purification and characterization of a plasminogen activator secreted by a pig kidney cell line.
Sudol M; Reich E
Biochem J; 1984 May; 219(3):971-8. PubMed ID: 6430276
[TBL] [Abstract][Full Text] [Related]
16. Purification and partial characterization of plasminogen activator from human uterine tissue.
Rijken DC; Wijngaards G; Zaal-de Jong M; Welbergen J
Biochim Biophys Acta; 1979 Sep; 580(1):140-53. PubMed ID: 121055
[TBL] [Abstract][Full Text] [Related]
17. Effect of sodium butyrate on alkaline phosphatase in HRT-18, a human rectal cancer cell line.
Morita A; Tsao D; Kim YS
Cancer Res; 1982 Nov; 42(11):4540-5. PubMed ID: 7127294
[TBL] [Abstract][Full Text] [Related]
18. Effect of butyric acid on lung-colonizing ability of cloned low-metastatic Lewis lung carcinoma cells.
Takenaga K
Cancer Res; 1986 Mar; 46(3):1244-9. PubMed ID: 3943096
[TBL] [Abstract][Full Text] [Related]
19. Secretion of plasminogen activators by cultured bovine endothelial cells: partial purification, characterization and evidence for multiple forms.
Laug WE
Thromb Haemost; 1981 Jun; 45(3):219-24. PubMed ID: 7197062
[TBL] [Abstract][Full Text] [Related]
20. Purification of human tissue-type plasminogen activator in centigram quantities from human melanoma cell culture fluid and its conditioning for use in vivo.
Collen D; Rijken DC; Van Damme J; Billiau A
Thromb Haemost; 1982 Dec; 48(3):294-6. PubMed ID: 6891842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
